F De Cobelli
Overview
Explore the profile of F De Cobelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1133
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belladelli F, De Cobelli F, Piccolo C, Cei F, Re C, Musso G, et al.
Urol Oncol
. 2024 Nov;
43(4):270.e1-270.e8.
PMID: 39516081
Objective: Renal Tumor biopsy (RTB) can assist clinicians in determining the most suitable approach for treatment of renal cancer. However, RTB's limitations in accurately determining histology and grading have hindered...
2.
Fiorino C, Palumbo D, Mori M, Palazzo G, Pellegrini A, Albarello L, et al.
Radiother Oncol
. 2024 Feb;
194:110160.
PMID: 38369025
Purpose: The early regression index (ERI) predicts treatment response in rectal cancer patients. Aim of current study was to prospectively assess tumor response to neoadjuvant chemo-radiotherapy (nCRT) of locally advanced...
3.
di Filippo L, La Marca S, Losa M, Lena M, Mapelli R, Incampo G, et al.
J Endocrinol Invest
. 2022 Oct;
46(4):763-768.
PMID: 36269557
Purpose: Adrenal cortical adenomas (ACAs) represent one of the most common endocrine neoplasms. Recently, a genetic syndrome, characterized by tumor-suppressor ARMC5-gene mutations and causing primary macronodular bilateral adrenal hyperplasia with...
4.
Rimini M, Rimassa L, Ueshima K, Burgio V, Shigeo S, Tada T, et al.
ESMO Open
. 2022 Oct;
7(6):100591.
PMID: 36208496
Background: A growing body of evidence suggests that non-viral hepatocellular carcinoma (HCC) might benefit less from immunotherapy. Materials And Methods: We carried out a retrospective analysis of prospectively collected data...
5.
Korenblik R, Olij B, Aldrighetti L, Abu Hilal M, Ahle M, Arslan B, et al.
Cardiovasc Intervent Radiol
. 2022 Jul;
45(9):1391-1398.
PMID: 35790566
Study Purpose: The DRAGON 1 trial aims to assess training, implementation, safety and feasibility of combined portal- and hepatic-vein embolization (PVE/HVE) to accelerate future liver remnant (FLR) hypertrophy in patients...
6.
Mapelli P, Bezzi C, Palumbo D, Canevari C, Ghezzo S, Samanes Gajate A, et al.
Eur J Nucl Med Mol Imaging
. 2022 Feb;
49(7):2352-2363.
PMID: 35156146
Purpose: To explore the role of fully hybrid Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine tumours (PanNETs) undergoing surgery. Methods: One...
7.
Leone R, Sferruzza G, Calimeri T, Steffanoni S, Conte G, De Cobelli F, et al.
Eur J Radiol
. 2021 Sep;
143:109945.
PMID: 34492625
Objective: To investigate the role of quantitative muscle biomarkers assessed with skeletal muscle index at the third lumbar vertebra (L3-SMI) and temporal muscle thickness (TMT) in predicting progression-free and overall...
8.
Palmisano A, Di Chiara A, Esposito A, Rancoita P, Fiorino C, Passoni P, et al.
Clin Radiol
. 2020 Jul;
75(10):798.e1-798.e11.
PMID: 32712007
Aim: To investigate the role of diffusion-weighted imaging (DWI), T2-weighted (W) imaging, and apparent diffusion coefficient (ADC) histogram analysis before, during, and after neoadjuvant chemoradiotherapy (CRT) in the prediction of...
9.
Dong D, Fang M, Tang L, Shan X, Gao J, Giganti F, et al.
Ann Oncol
. 2020 Apr;
31(7):912-920.
PMID: 32304748
Background: Preoperative evaluation of the number of lymph node metastasis (LNM) is the basis of individual treatment of locally advanced gastric cancer (LAGC). However, the routinely used preoperative determination method...
10.
Filippiadis D, Mauri G, Marra P, Charalampopoulos G, Gennaro N, De Cobelli F
Int J Hyperthermia
. 2019 Sep;
36(2):21-30.
PMID: 31537160
Percutaneous ablation is an increasingly applied technique for the treatment of localized renal tumors, especially for elderly or co-morbid patients, where co-morbidities increase the risk of traditional nephrectomy. Ablative techniques...